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To the Editor:
Dysplastic findings in blood cells arise due to any challenge 
during the course of normal differentiation and can be 
encountered in autoimmune disorders (1–3).
Some myelodysplastic findings closely overlap with 
features of cellular senescence, which may be dependent 
on or independent of telomeres. The latter case is due to 
severe DNA damage, oncogenes, oxidative stress, and 
strong mitogenic signals (4).
No hallmark of senescence has been identified yet. 
Salient features of senescent cells are: 1) permanent 
growth arrest (generally in G1); 2) increased cell size 
and polyploidy; 3) expression of senescence-associated 
β-galactosidase (SA-β-gal) activity; 4) expression of 
p16INK4a in some of them, which causes reorganization 
of heterochromatin as punctate highly condensed domains 
of facultative heterochromatin [(senescence-associated 
heterochromatin foci (SAHF)] that silence critical 
proproliferative genes; 5) DNA damage response (DDR), 
which initiates and maintains the senescence growth 
arrest; and 6) secretion of growth factors, proteases, and 
cytokines by senescent cells with persistent DDR signaling 
(senescence-associated secretory phenotype) (5). 
Alterations in cell cycle and reorganization in the genome is 
accompanied by altered cytokinesis, karyokinesis, cellular 
scaffolding and alterations in cell morphology, formation 
of micronuclei (6) or fragmented nuclei, flattened cell 
shape, and intracellular vacuoles (7–9). 
Herein, we aimed to investigate the coexistence of 
cellular senescence with myelodysplastic findings in 
patients with juvenile rheumatoid arthritis (JRA, n = 2), 
systemic lupus erythematosus (SLE, n = 1), acute immune 
thrombocytopenic purpura (ITP, n = 1) and chronic 
ITP (n = 1). SLE and chronic ITP patients were not on 
any therapy for at least 45 days; the others were at first 
admission (age: 11.6 ± 4.61 years; 2 females, 3 males; 
controls: 13.66 ± 4.16). The leukocytes were prepared and 
stained by SA-β-gal (8).
All patients had dysmorphic blood cells on blood 
smears (up to 80% vs. 25% in the controls). The leukocytes 
of all patients displayed positive SA-β-gal staining (by 
33%–57% vs. 0% in the controls) (Figure 1) .
In our patients, we could not test all features of 
cellular senescence, but not all senescent cells express all 
possible senescence markers (5). In our patients, SA-β-
gal positivity, increased cell size and increased chromatin 
clumping, which mimics nuclear fragmentation (10), and 
SAHF are compatible with cellular senescence. 
We think that the proinflammatory cytokines and 
chemokines in SLE, JRA-PT, and ITP patients (11–13) led 
to cellular senescence (14) by keeping the immune system 
in a state of chronic low-level activation and giving rise to 
immunosenescence through loss of telomeres with each S 
phase (5), which was increased by inflammatory mediators 
that are secreted by senescent cells themselves (14). 
Additionally, destruction of tissue environment and stem 
cell niches (14) by inflammatory mediators, proteases, 
and immune cells may have exacerbated aging through 
hematopoietic stem cell dysfunction, altered mitosis, and 
dysmorphism.
Essentially, decline in absolute number of T (CD8+, 
CD4+) and B lymphocytes (15) in immunosenescence, 
abnormal telomere/telomerase system in ITP (16), and 
accelerated loss of T cells in juvenile idiopathic arthritis 
(17) were reported.
In conclusion, these results suggest that cellular 
senescence plays a role in the pathogenesis of autoimmune 
disorders and myelodysplastic features may be a reflection 
of cellular senescence. Further studies are needed for 
confirmation.
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Figure 1. Dysmorphic hematological features of the peripheral blood smears of patient ASİ with chronic ITP (a–g), patient MEY with 
JRA (h–n), and patient TÇ with JRA (o–x). 
Neutrophils: Macropolycytes (neutrophil of ≥15 µm) (b, c, h, i), hypersegmentation (c), cytoplasmic vacuoles (a), hypogranulation (d, 
o), cytoplasmic protrusions with or without granules (h, k), irregular distribution of granules (a, c, j), abnormal nuclei with nucleic 
protrusions (q, r), neutrophils with long chromatin between the nuclei (j, o), pseudo-Pelger–Huet cells (o, p). Lymphocytes: Cytoplasmic 
protrusions (e, n, u, v, w). Basophils: Centralization of granules (f), abnormal nuclei and hypogranulation (x). Monocytes: Abnormal 
nuclei (g, s, t), cytoplasmic vacuoles (g, s), cytoplasmic protrusion (g). Platelets: Big or giant platelets (l, m). β-Gal staining photographs 
of the patients: Patient TÇ with JRA (y), patient MBY with JRA (z), patient KÇ with SLE (aa), patient HA with acute ITP (ab), patient 
ASİ with chronic ITP (ac), and control (ad) (100×). 
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